Zobrazeno 1 - 10
of 182
pro vyhledávání: '"TOMOHIRO MIZUNO"'
Autor:
Tomohiro Mizuno, Fumihiko Nagano, Kazuo Takahashi, Shigeki Yamada, Kazuhiro Fruhashi, Shoichi Maruyama, Naotake Tsuboi
Publikováno v:
FEBS Open Bio, Vol 14, Iss 4, Pp 574-583 (2024)
Acute lung injury (ALI), which occurs in association with sepsis, trauma, and coronavirus disease 2019 (COVID‐19), is a serious clinical condition with high mortality. Excessive platelet‐leukocyte aggregate (PLA) formation promotes neutrophil ext
Externí odkaz:
https://doaj.org/article/28cdf854a5a84a089cd6e47f522681f3
Autor:
Noriaki Matsumoto, Tsuyoshi Nakai, Mikio Sakakibara, Yukinori Aimiya, Shinya Sugiura, Jeannie K. Lee, Shigeki Yamada, Tomohiro Mizuno
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Hypertension is a major cause of cardiovascular diseases. Several recent studies reported that pharmacists’ remote follow-up reduced hypertension patients’ blood pressure (BP). This meta-analysis aims to verify whether remote follow-up b
Externí odkaz:
https://doaj.org/article/259e43646f2c487ab80ec45447a76727
Publikováno v:
Fujita Medical Journal, Vol 9, Iss 2, Pp 73-79 (2023)
Objectives: Patients with cancer, especially those with lung cancer, are at high risk of developing thrombosis. Intralipos® infusion 20% is contraindicated for thrombosis, and there is no consensus on whether it can be safely used in cases of advanc
Externí odkaz:
https://doaj.org/article/3dd889bc0cf5427da7577f338100da18
Autor:
Takenao Koseki, Kazuki Nakajima, Hitoshi Iwasaki, Shigeki Yamada, Kazuo Takahashi, Yohei Doi, Tomohiro Mizuno
Publikováno v:
International Journal of Infectious Diseases, Vol 115, Iss , Pp 218-223 (2022)
Objectives: Favipiravir is an antiviral that is being evaluated for the treatment of COVID-19. Use of favipiravir is associated with elevation of serum uric acid levels. Risk factors for the occurrence of hyperuricemia are unclear. Methods: Specimens
Externí odkaz:
https://doaj.org/article/c22d30a61d6649de8e313e7f4e25aa1d
Autor:
Fumihiko Nagano, Tomohiro Mizuno, Masaki Imai, Kazuo Takahashi, Naotake Tsuboi, Shoichi Maruyama, Masashi Mizuno
Publikováno v:
FEBS Open Bio, Vol 12, Iss 1, Pp 192-202 (2022)
Acute lung injury (ALI) occurs in patients with severe sepsis and has a mortality rate of 40%–60%. Severe sepsis promotes the release of histones from dying cells, which can induce platelet aggregation, activate coagulation and cause endothelial ce
Externí odkaz:
https://doaj.org/article/65e0ac3b30114d7d945fdd68e6189f65
Autor:
Koki Kato, Tomohiro Mizuno, Takenao Koseki, Yoshimasa Ito, Kazuo Takahashi, Naotake Tsuboi, Shigeki Yamada
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Information on immune checkpoint inhibitor-induced vasculitides is limited, and predictors for this condition have not been identified. Therefore, we have examined the frequency of immune checkpoint inhibitor-induced vasculitides by analyzing the dat
Externí odkaz:
https://doaj.org/article/06b230a4c1804afb9c22464295d35eab
Autor:
Shogo Nishimoto, Tomohiro Mizuno, Kazuo Takahashi, Fumihiko Nagano, Yukio Yuzawa, Akira Nishiyama, Kenji Osafune, Hirofumi Hitomi, Tadashi Nagamatsu
Publikováno v:
FEBS Open Bio, Vol 10, Iss 3, Pp 427-433 (2020)
Renal anemia in chronic kidney disease is treated with recombinant human erythropoietin (rhEPO). However, some patients with anemia do not respond well to rhEPO, emphasizing the need for a more biocompatible EPO. Differentiation protocols for hepatic
Externí odkaz:
https://doaj.org/article/757d729b4e104452891a5aacfda045ea
Autor:
Takaya Okawa, Tomohiro Mizuno, Shogo Hanabusa, Takeshi Ikeda, Fumihiro Mizokami, Takenao Koseki, Kazuo Takahashi, Yukio Yuzawa, Naotake Tsuboi, Shigeki Yamada, Yoshitaka Kameya
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262021 (2022)
BackgroundEarly detection and prediction of cisplatin-induced acute kidney injury (Cis-AKI) are essential for the management of patients on chemotherapy with cisplatin. This study aimed to evaluate the performance of a prediction model for Cis-AKI.Me
Externí odkaz:
https://doaj.org/article/6e47e0127bc6441b957d514a7d16d03d
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background The number of patients aged 80 years or older with diffuse large B-cell lymphoma (DLBCL) is increasing, and the incidence rate of the disease in this population group reaches up to 20%. The risk of infection is higher in older patients tha
Externí odkaz:
https://doaj.org/article/ee8d49e4bf2c46228ba37874b6a4a0a2
Autor:
Ayako Kondo, Kazuo Takahashi, Hisateru Yamaguchi, Yuri Yoshida, Tomohiro Mizuno, Kazuki Nakajima, Hiroki Hayashi, Shigehisa Koide, Daijo Inaguma, Midori Hasegawa, Yoshiyuki Hiki, Yukio Yuzawa
Publikováno v:
Fujita Medical Journal, Vol 4, Iss 2, Pp 36-41 (2018)
IgA1 with galactose (Gal)-deficient hinge-region (HR) O-glycans (Gd-IgA1) plays a key role in IgA nephropathy (IgAN), and the serum level of Gd-IgA1 is elevated in the majority of IgAN patients. To characterize the involvement of IgA1 in the developm
Externí odkaz:
https://doaj.org/article/f0fe6c9274a745f0b77c87faa6948544